Company Overview
- Website
- phase3group.com
- Employees
- 4
- Industry
- Education/Training
- SIC Code
-
9411 - Administration of Educational Programs
Financials & Stats
Revenue
$3B
Recent News & Media
Formycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206
- Jul 10, 2025
- tradingview.com
FM Phase-III batch III e-auction sees competitive start with five intense clock rounds completed on Day 1
- Jul 9, 2025
- storyboard18.com
Taiho’s Oral, Mutation-Agnostic DMD Candidate Misses Phase III Endpoint
- Jul 9, 2025
- insights.citeline.com
Intellia Therapeutics (NTLA) Soars 9.08% on Phase III Trial
- Jul 9, 2025
- ainvest.com
Recurrence Patterns of Esophageal Adenocarcinoma in the Phase III ESOPEC Trial Comparing Perioperative Chemotherapy With Preoperative Chemoradiotherapy
- Jul 9, 2025
- ascopubs.org
Cogent pivots from Phase III to US$200m equity raise
- Jul 9, 2025
- ifre.com
Companies Similar to PHASE III
Analyze industry trends and opportunities by examining competitors and companies comparable to PHASE III, including their performance metrics, financials, growth dynamics, and competitive benchmarks.
| Company Name | Revenue | Number of Employees | Location | Founded in |
|---|---|---|---|---|
| 3M | 12 | Charlotte, NC | ||
| 3M | 17 | Albany, NY | ||
| 3M | 3 | Austin, TX | 2012 | |
| 3M | 41 | New York, NY | 2019 | |
| 3M | 10 | New York, NY | 2008 |